Humanin Is a Novel Neuroprotective Agent Against Stroke
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background and Purpose— Humanin (HN) is a 24-amino acid peptide best known for its ability to protect neurons from damage caused by Alzheimer disease-related proteins. This study examines the neuroprotective effects of HNG (a potent form of HN) on focal cerebral ischemia/reperfusion injury in mice. Methods— Mice underwent middle cerebral artery occlusion for 75 minutes followed by 24-hour reperfusion. Mice were pretreated with 0.1 μg HNG (intracerebroventricularly) 30 minutes before ischemia; posttreated at 0, 2, 4, and 6 hours after ischemia; or pretreated with 1 μg HNG (intraperitoneally) 1 hour before ischemia. Neurological deficits and cerebral infarct volume were evaluated. Neuronal apoptosis and activated poly(ADP-ribose) polymerase expression were measured by TUNEL and Western blot analysis, respectively. Activated ERKs were examined by Western blot analysis. Results— Pretreatment with 0.1 μg HNG (intracerebroventricularly) 30 minutes before ischemia reduced cerebral infarct volume from 56.2±3.0% to 26.1±1.4% ( P <0.01). HNG posttreatment after 4 hours of reperfusion reduced cerebral infarct volume to 45.6±2.6% ( P <0.05). Pretreatment with 1 μg HNG (intraperitoneally) 1 hour before ischemia or posttreatment after 2 hours of reperfusion reduced cerebral infarct volume significantly. HNG also significantly improved neurological function and inhibited both neuronal apoptosis as well as poly(ADP-ribose) polymerase activation. A significant decrease of phospho-ERK was observed in mice treated with HNG, whereas phospho-JNK and phospho-p38 levels were not altered. Conclusions— Our results demonstrate that HNG protects against cerebral ischemia/reperfusion injury in mice. HNG offers neuroprotection in vivo at least in part by inhibiting ERK activation. These findings suggest a potential therapeutic role for HNG in the treatment of stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Semiautomated Method for Measuring Brain Infarct Volume
Swanson, R. A., Morton, M. T., Tsao-Wu, G., Savalos, R. A., Davidson, C., & Sharp, F. R. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.47 · Cited by 1,644
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402
Hashimoto, Y., Niikura, T., Tajima, H., Yasukawa, T., Sudo, H., Ito, Y., Kita, Y., Kawasumi, M., Kouyama, K., Doyu, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101133498 · Cited by 623 · cited 1×
“Animals were randomly divided into four groups (n 6–8): (1) sham group; (2) HNG-treated group (HN group); (3) vehicle-treated I/R”
MethodHumanin peptide suppresses apoptosis by interfering with Bax activation
Guo, B., Zhai, D., Cabezas, E., Welsh, K., Nouraini, S., Satterthwait, A. C., & Reed, J. C. (2003) · Nature · doi:10.1038/nature01627 · Cited by 617
Yang, G., Chan, P. H., Chen, J., Carlson, E., Chen, S. F., Weinstein, P., Epstein, C. J., & Kamii, H. (1994) · Stroke · doi:10.1161/01.str.25.1.165 · Cited by 567
Stanciu, M., Wang, Y., Kentor, R., Burke, N., Watkins, S., Kress, G., Reynolds, I., Klann, E., Angiolieri, M. R., Johnson, J. W., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12200 · Cited by 539
MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia
Alessandrini, A., Namura, S., Moskowitz, M. A., & Bonventre, J. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12866 · Cited by 464
Jovanovic, J. N., Benfenati, F., Siow, Y. L., Sihra, T. S., Sanghera, J. S., Pelech, S. L., Greengard, P., & Czernik, A. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3679 · Cited by 393
Role of Mitogen- and Stress-Activated Kinases in Ischemic Injury
Irving, E. A., & Bamford, M. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200206000-00001 · Cited by 367
Namura, S., Iihara, K., Takami, S., Nagata, I., Kikuchi, H., Matsushita, K., Moskowitz, M. A., Bonventre, J. V., & Alessandrini, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181213498 · Cited by 360
Cited by
SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons
Li, Y., Xu, W., McBurney, M. W., & Longo, V. D. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.004 · Cited by 331
Humanin: a harbinger of mitochondrial-derived peptides
Lee, C., Yen, K., & Cohen, P. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.01.005 · Cited by 284
Zheng, J., Shi, L., Liang, F., Xu, W., Li, T., Gao, L., Sun, Z., Yu, J., & Zhang, J. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00414 · Cited by 173
The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan
Yen, K., Mehta, H. H., Kim, S.-J., Lue, Y., Hoang, J., Guerrero, N., Port, J., Bi, Q., Navarrete, G., Brandhorst, S., et al. (2020) · Aging · doi:10.18632/aging.103534 · Cited by 106
Metadata
- Authors
- Xu, X., Chua, C. C., Gao, J., Hamdy, R. C., & Chua, B. H. L.
- Venue
- Stroke
- Published
- 2006-10
- Volume
- 37
- Issue
- 10
- Pages
- 2613-2619
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2096805220
- Cited by
- 168
- References
- 28
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Humanin Is a Novel Neuroprotective Agent Against Stroke. https://app.cochat.ai/papers/10.1161/01.str.0000242772.94277.1f
- The paper
- Xu, X., Chua, C. C., Gao, J., Hamdy, R. C., & Chua, B. H. L. (2006). Humanin Is a Novel Neuroprotective Agent Against Stroke. Stroke. https://doi.org/10.1161/01.str.0000242772.94277.1f
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.